Albrechtsen, Hanne, and Elin K. Jacob. 1998.

The Dynamics of Classification Systems as Boundary Objects for Cooperation in the Electronic Library. Library Trends 47, no. 2: 293-312. Anderson, M J. 1993. Collaborative integration in the Canadian pharmaceutical industry. Environment and Planning A 25, no. 12: 1815 – 1838. doi:10.1068/a251815. Anon. The Diffusion of Information Technology among Health Maintenance Organizations 25. http://journals.lww.com/hcmrjournal/Fulltext/2000/04000/ The_Diffusion_of_Information_Technology_among.3.aspx. Berndt, Ernst R. 2001. The U.S. Pharmaceutical Industry: Why Major Growth In Times Of Cost Containment? Health Aff 20, no. 2 (March 1): 100-114. doi: 10.1377/hlthaff.20.2.100. Bharadwaj, Anandhi S., Sundar G. Bharadwaj, and Benn R. Konsynski. 1999. Information Technology Effects on Firm Performance as Measured by Tobin's q. Management Science 45, no. 7 (July): 1008-1024. Birnbaum H.G.[1], Cremieux P.Y.[1], Greenberg P.E.[1], LeLorier J.[2], Ostrander J.[1], and Venditti L.[1]. 1999. Using Healthcare Claims Data for Outcomes Research and Pharmacoeconomic Analyses. PharmacoEconomics 16 (July): 1-8. Boudreau, Marie-Claude, Karen D. Loch, Daniel Robey, and Detmar Straud. 1998. Going Global: Using Information Technology to Advance the Competitiveness of the Virtual Transnational Organization. The Academy of Management Executive (1993) 12, no. 4 (November): 120-128. Carl Sherman. 2001. Lithium Decline Reflects Economic, Not Clinical Trends: Since 1965, 24 studies have reported a drop in bipolar recurrence with lithium 29, no. 12 (December 1): 1. Carter, Franklin J., Thani Jambulingam, Vipul K. Gupta, and Nancy Melone. 2001. Technological innovations: a framework for communicating diffusion effects. Information & Management 38, no. 5 (April): 277-287. doi:10.1016/ S0378-7206(00)00065-3. Chen, Yu-Shan, and Ke-Chiun Chang. 2009. Using neural network to analyze the influence of the patent performance upon the market value of the US pharmaceutical companies. Scientometrics 80, no. 3 (4): 637-655. doi: 10.1007/s11192-009-2095-2. Chilvers, Jason, and James Evans. 2009. Understanding networks at the science-policy interface. Geoforum 40, no. 3 (May): 355-362. doi:10.1016/

j.geoforum.2009.03.007. Clarke, Adele, and Virginia L. Olesen. 1999. Revisioning women, health and healing. Routledge. DESHPANDE, APARNA [1], AJIT [1] MENON, MATTHEW [1] PERRI III, and GEORGE [2] ZINKHAN. 2004. Direct-to-Consumer Advertising and its Utility in Health Care Decision Making: A Consumer Perspective. Journal of Health Communication 9 (December): 499-513. doi:10.1080/10810730490523197. Dormann, H., A. Neubert, M. Criegee-Rieck, T. Egger, M. Radespiel-Tröger, T. Azaz-Livshits, M. Levy, K. Brune, and E.G. Hahn. 2004. Readmissions and adverse drug reactions in internal medicine: the economic impact. Journal of Internal Medicine 255, no. 6: 653-663. doi:10.1111/j. 1365-2796.2004.01326.x. Fairman, Kathleen A, and Frederic R Curtiss. 2007. The elephant in the pharmacy: patient choice is the big challenge that no one talks about in affordability of prescription drugs. Journal of Managed Care Pharmacy: JMCP 13, no. 7 (September): 620-622. Fountoulakis, Konstantinos N., Eduard Vieta, Constantin Bouras, Grigorios Notaridis, Panteleimon Giannakopoulos, George Kaprinis, and Hagop Akiskal. 2007. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? The International Journal of Neuropsychopharmacology 11, no. 02 (5). doi:10.1017/S1461145707007821. http://www.journals.cambridge.org/abstract_S1461145707007821. GORMAN, M. E. 2004. Collaborating on convergent technologies. Ann. NY Acad. Sci 1013: 1–13. Haraway, Donna. 1988. Situated Knowledges: The Science Question in Feminism and the Privilege of Partial Perspective. Feminist Studies 14, no. 3 (Autumn): 575-599. Henegar, Corneliu, Cédric Bousquet, Agnès Lillo-Le Louët, Patrice Degoulet, and Marie-Christine Jaulent. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance. Computers in Biology and Medicine 36, no. 7-8 (July): 748-767. doi:10.1016/j.compbiomed. 2005.04.009. Herasevich, Vitaly, Mark T. Keegan, David Tines, Michael M. Malinchoc, Andrew C. Hanson, Puneet Katyal, Rolf D. Hubmayr, Bekele Afessa, and Ognjen Gajic. 2007. "ICU of the future": informatics infrastructure for syndrome surveillance, decision support, data mining, and modeling of critical illness. Journal of Critical Care 22, no. 4 (December): 340. doi:10.1016/

j.jcrc.2007.10.016. Hickman, C. 2009. Cheerful prospects and tranquil restoration: the visual experience of landscape as part of the therapeutic regime of the British asylum, 1800--60. History of Psychiatry 20, no. 4 (11): 425-441. doi: 10.1177/0957154X08338335. Jaakkola, Elina, and Maija Renko. 2007. Critical innovation characteristics influencing the acceptability of a new pharmaceutical product format. Journal of Marketing Management 23 (April): 327-346. doi: 10.1362/026725707X196404. Jennings, Pamela. 2005. Tangible social interfaces: critical theory, boundary objects and interdisciplinary design methods. In Proceedings of the 5th conference on Creativity ###BOT_TEXT###amp;amp; cognition, 176-186. London, United Kingdom: ACM. doi:10.1145/1056224.1056249. http://portal.acm.org/ citation.cfm?id=1056249. Jones, Judith K. 2001. The role of data mining technology in the identification of signals of possible adverse drug reactions: value and limitations. Current Therapeutic Research 62, no. 9 (September): 664-672. doi:10.1016/S0011-393X(01)80072-2. Jones, Peter B., Thomas R. E. Barnes, Linda Davies, Graham Dunn, Helen Lloyd, Karen P. Hayhurst, Robin M. Murray, Alison Markwick, and Shon W. Lewis. 2006. Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 63, no. 10 (October 1): 1079-1087. doi:10.1001/ archpsyc.63.10.1079. Kraut, Robert, Charles Steinfield, Alice P. Chan, Brian Butler, and Anne Hoag. 1999. Coordination and Virtualization: The Role of Electronic Networks and Personal Relationships. Organization Science 10, no. 6 (December): 722-740. Lankinen, Kari S., Tero Levola, Kati Marttinen, Inka Puumalainen, and Arja Helin-Salmivaara. 2004. Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals. Pharmacoepidemiology and Drug Safety 13, no. 11: 789-795. doi:10.1002/pds.1017. Mather, Charles M. 2006. Medical innovation, unmet medical needs, and the drug pipeline. The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique 13, no. 1: e85-91. Moore, Thomas J., Bruce M. Psaty, and Curt D. Furberg. 1998. Time to Act on

Drug Safety. JAMA 279, no. 19 (May 20): 1571-1573. doi:10.1001/jama. 279.19.1571. Moynihan, Ray, Iona Heath, David Henry, and Peter C Gotzsche. 2002. Selling sickness: the pharmaceutical industry and disease mongering * Commentary: Medicalisation of risk factors. BMJ 324, no. 7342 (April 13): 886-891. doi: 10.1136/bmj.324.7342.886. Muldoon, Chris. 2004. Pharmaceutical advertising: fact or fiction? Pharmacoepidemiology and Drug Safety 13, no. 11: 801-802. doi:10.1002/pds. 1011. Nelson R.C.[1], Palsulich B.[2], and Gogolak V.[3]. 2002. Good Pharmacovigilance Practices: Technology Enabled. Drug Safety 25: 407-414. O'Grady, Laura. 2006. Future directions for depicting credibility in health care web sites. International Journal of Medical Informatics 75, no. 1 (January): 58-65. doi:10.1016/j.ijmedinf.2005.07.035. O'Neill, Robert T., and Ana Szarfman. 2001. Some US Food and Drug Administration perspectives on data mining for pediatric safety Assessment. Current Therapeutic Research 62, no. 9 (September): 650-663. doi:10.1016/ S0011-393X(01)80071-0. Orman, Levent V. 2002. Electronic Markets, Hierarchies, Hubs, and Intermediaries. Information Systems Frontiers 4, no. 2 (July 1): 213-228. doi:10.1023/A:1016007020846. Pearson, Ronald K., Manfred Hauben, David I. Goldsmith, A. Lawrence Gould, David Madigan, Donald J. O'Hara, Stephanie J. Reisinger, and Alan M. Hochberg. 2009. Influence of the MedDRA® hierarchy on pharmacovigilance data mining results. International Journal of Medical Informatics 78, no. 12 (December): e97-e103. doi:10.1016/j.ijmedinf.2009.01.001. Power, Michael. 2005. The Invention of Operational Risk. Review of International Political Economy 12, no. 4 (October): 577-599. Rai, Arti K. 2001. The Information Revolution Reaches Pharmaceuticals: Balancing Innovation Incentives, Cost, and Access in the Post-Genomics Era. University of Illinois Law Review 2001 (January 1): 173-210. Revicki, Dennis A, Robert M A Hirschfeld, Eileen P Ahearn, Richard H Weisler, Cynthia Palmer, and Paul E Keck. 2005. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial. Journal of Affective Disorders 86, no. 2-3 (June): 183-193. doi:10.1016/j.jad.2005.01.002.

Rizzo, John A. 1999. Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs. The Journal of Law and Economics 42, no. 1: 89-116. Rosoff, Arnold J. 1997. Changing Face of Pharmacy Benefits Management: Information Technology Pursues a Grand Mission, The. Saint Louis University Law Journal 42: 1. Ruhleder, Karen, and John Leslie King. 1991. Computer support for work across space, time, and social worlds. Journal of Organizational Computing and Electronic Commerce 1, no. 4: 341. doi:10.1080/10919399109540168. Sachs, G. S, C. F Baldassano, C. J Truman, and C. Guille. 2000. Comorbidity of attention deficit hyperactivity disorder with early-and late-onset bipolar disorder. American Journal of Psychiatry 157, no. 3: 466. Sraffa, Piero. 1926. The Laws of Returns under Competitive Conditions. The Economic Journal 36, no. 144 (December): 535-550. Star, Susan Leigh, and James R. Griesemer. 1989. Institutional Ecology, `Translations' and Boundary Objects: Amateurs and Professionals in Berkeley's Museum of Vertebrate Zoology, 1907-39. Social Studies of Science 19, no. 3 (August 1): 387-420. doi:10.1177/030631289019003001. Steinfield, Charles William. 2003. New directions in research on ecommerce. Purdue University Press, December. Woolgar, Steve. 1988. Time and documents in researcher interaction: Some ways of making out what is happening in experimental science. Human Studies 11, no. 2 (April 1): 171-200. doi:10.1007/BF00177303. Yates, JoAnne, and John Van Maanen. 2001. Information technology and organizational transformation. SAGE.